Cargando…
Partially Randomized, Non-Blinded Trial of DNA and MVA Therapeutic Vaccines Based on Hepatitis B Virus Surface Protein for Chronic HBV Infection
BACKGROUND: Chronic HBV infects 350 million people causing cancer and liver failure. We aimed to assess the safety and efficacy of plasmid DNA (pSG2.HBs) vaccine, followed by recombinant modified vaccinia virus Ankara (MVA.HBs), encoding the surface antigen of HBV as therapy for chronic HBV. A secon...
Autores principales: | Cavenaugh, James S., Awi, Dorka, Mendy, Maimuna, Hill, Adrian V. S., Whittle, Hilton, McConkey, Samuel J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039644/ https://www.ncbi.nlm.nih.gov/pubmed/21347224 http://dx.doi.org/10.1371/journal.pone.0014626 |
Ejemplares similares
-
Application of real-time PCR to quantify hepatitis B virus DNA in chronic carriers in The Gambia
por: Mendy, Maimuna E, et al.
Publicado: (2006) -
Changes in viral load and HBsAg and HBeAg status with age in HBV chronic carriers in The Gambia
por: Mendy, Maimuna E, et al.
Publicado: (2008) -
KIR content genotypes associate with carriage of hepatitis B surface antigen, e antigen and HBV viral load in Gambians
por: Yindom, Louis-Marie, et al.
Publicado: (2017) -
Long-Term Protection against HBV Chronic Carriage of Gambian Adolescents Vaccinated in Infancy and Immune Response in HBV Booster Trial in Adolescence
por: van der Sande, Marianne A.B., et al.
Publicado: (2007) -
Emergence of HBV resistance to lamivudine (3TC) in HIV/HBV co-infected patients in The Gambia, West Africa
por: Stewart, Balint, et al.
Publicado: (2011)